Impact of Donor-Dependent Genetic Factors on Long-Term Renal Graft Function

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 2978-2980

  Krajewska, M ^a   Koscielska Kasprzak K ^a   Weyde, W ^a   Drulis Fajdasz, D ^a   Madziarska, K ^a   Mazanowska, O ^a   Kusztal, M ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FETUIN A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GEL ELECTROPHORESIS; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DELAYED GRAFT FUNCTION; GENE EXPRESSION PROFILING; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 70350516381     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.08.027     Document Type: Article

References (14)

1. Alkalin E., and Murphy B. Gene polymorphism and transplantation. Curr Opin Immunol 13 (2001) 572
2. Hoffmann S., Jacobson L.M., Muehrer R.J., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 66 (2004) 686
3. Laroux F.S., Pavlick K.P., Hines H.N., et al. Role of nitric oxide in inflammation. Acta Physiol Scand 173 (2001) 113
4. Segal M.S., Baylis C., and Johnson R.J. Endothelial health and diversity in the kidney. J Am Soc Nephrol 17 (2006) 323
5. Bellini M.H., Figueira M.N., Piccoli M.F., et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology 12 (2007) 289
6. Sezer S., Uyar M., Akcay A., et al. Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphism can influence chronic inflammatory state in renal transplant patients. Transplant Proc 37 (2005) 776
7. Wang Y., Pratt J.R., Hartely B., et al. Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor and persistent fibrin deposition in chronic renal allograft failure. Kidney Int 52 (1997) 371
8. Baricos W.H., Cortez S.L., al-Dahr S.S., et al. Extracellular degradation by cultured human mesangial cells is mediated by PA/plasmin/MMP-2 cascade. Kidney Int 47 (1995) 1039
9. Grandaliano G., Di P.S., Monno R., et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. Transplantation 72 (2001) 1437
10. Dawson S.J., Wiman B., Hamsten A., et al. The two allele sequences of common polymorphism in the promoter of the plasminogen activator inhibitor-1(PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268 (1993) 10739
11. He J.Q., Gaur L.K., Stempien-Otero A., et al. Genetic variants of the hemostatic system and development of transplant coronary artery disease. J Heart Lung Transplant 21 (2002) 629
12. Zeier M., Dohler B., Opelz G., et al. The effect of donor gender on graft survival. J Am Soc Nephrol 13 (2002) 2570
13. Kim M.S., Kim D.K., Myoung S.M., et al. Chronologically different impacts of immunologic and non-immunologic risk factors on renal allograft function. Clin Transplant 19 (2005) 742
14. Moreso F., Seron D., Gil-Vernet S., et al. Donor age and delayed graft function as predictors of renal graft survival in rejection free patients. Nephrol Dial Transplant 14 (1999) 930